Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline XTNT Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain KinderCare Learning KLC Q1 2026 Earnings Strong EPS Beat Despite Revenue Discretion PFE Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Focus LAC Q1 2026 Earnings NarrowerthanExpected Loss Underscores Project Progress Stock Slips VELO Q1 2026 Earnings NarrowerthanExpected Loss Drives DoubleDigit Stock Surge